7 November 2022

New fluorescent tools to evaluate the therapeutic potential of phytocannabinoids

Cannabinoid receptors, CB1 and CB2 are two extensively studied targets of the GPCR family for the treatment of numerous conditions, including inflammatory diseases, autoimmune disorders, pain, […]